Balipodect 50 mg | 99.28%
TargetMol
Balipodect (TAK063) is a highly effective and selective PDE10A inhibitor (IC50: 0.30 nM); Its selectivity is >15000-fold over other PDEs.
More Information Supplier PageBalipodect (TAK063) is a highly effective and selective PDE10A inhibitor (IC50: 0.30 nM); Its selectivity is >15000-fold over other PDEs.
More Information Supplier PageBalipodect (TAK063) is a highly effective and selective PDE10A inhibitor (IC50: 0.30 nM); Its selectivity is >15000-fold over other PDEs.
More Information Supplier PageOtenabant hydrochloride (CP-945598) is a competitive, high affinity, selective antagonist of the CB1 receptor (Ki: 0.7 nM).
More Information Supplier PageOtenabant hydrochloride (CP-945598) is a competitive, high affinity, selective antagonist of the CB1 receptor (Ki: 0.7 nM).
More Information Supplier PageEverolimus is a potent mTOR inhibitor that binds to FKBP-12. It is used alone or in combination with calcineurin inhibitors.
More Information Supplier PageEverolimus is a potent mTOR inhibitor that binds to FKBP-12. It is used alone or in combination with calcineurin inhibitors.
More Information Supplier PageSB742457 is a highly selective 5-HT6 receptor antagonist, used in trials studying the treatment of Alzheimer’s Disease.
More Information Supplier PageSB742457 is a highly selective 5-HT6 receptor antagonist, used in trials studying the treatment of Alzheimer’s Disease.
More Information Supplier PageOlmesartan Medoxomil (Benicar) is an angiotensin II type 1 receptor blocker that is used to manage hypertension.
More Information Supplier PageOlmesartan Medoxomil (Benicar) is an angiotensin II type 1 receptor blocker that is used to manage hypertension.
More Information Supplier Page